Phosplatin Therapeutics
New York, US
Biotech
Founders & leadership
FB
Frances BonhamExecutive Officer
RF
Robert FallonExecutive Officer, Director
MP
Matthew PriceExecutive Officer, Director
PE
Peter EspigDirector
JC
John CaouetteDirector
RL
Rosita LeongDirector
JP
John PorterDirector
Reported raises · per SEC filings
Form D private placements$37.3MraisedDec 2021 · 41 investors · Pharmaceuticals
Rule 506(b)$18.4MraisedAug 2020 · 40 investors · Pharmaceuticals
Rule 506(b)$16.6MraisedNov 2018 · 48 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.